1. Phenethylbiguanide inhibits the synthesis of phosphoenolpyruvate from malate or 2-oxoglutarate by isolated guinea-pig liver mitochondria. This inhibition is time-and concentration-dependent, with the maximum decrease in the rate of phosphoenolpyruvate synthesis (80%) evident after 10min of incubation with 1 mM-phenethylbiguanide. 2. The phosphorylation of ADP by these mitochondria is also inhibited at increasing concentrations of phenethylbiguanide and there is a progressive increase in AMP formation. Guinea-pig liver mitochondria are more sensitive to this inhibition in oxidative phosphorylation caused by phenethylbiguanide than are rat liver mitochondria. 3. Simultaneous measurements of 02 consumption and ADP phosphorylation with guinea-pig liver mitochondria oxidizing malate plus glutamate in State 3 indicated that phenethylbiguanide at low concentrations (0.1 mM) inhibits respiration at Site 1. At higher phenethylbiguanide concentrations Site 2 is also inhibited. 4. Gluconeogenesis from lactate, pyruvate, alanine and glycerol by isolated perfused guinea-pig liver is inhibited to various degrees by phenethylbiguanide. Alanine is the most sensitive to inhibition (60% inhibition of the maximum rate by 0.1 mM-phenethylbiguanide), whereas glycerol is relatively insensitive (25% inhibition at 4mM). 5. Gluconeogenesis from lactate and pyruvate by perfused rat liver was also inhibited by phenethylbiguanide, but only at high concentrations (8 mM). Unlike guinea-pig liver, the inhibitory effect of phenethylbiguanide on rat liver was reversible after the termination of phenethylbiguanide infusion. 6. The time-course of inhibition of gluconeogenesis from the various substrates used in this study indicated a time-dependency which was related in part to the concentration ofinfused phenethylbiguanidine. This time-course closely paralleled that noted for the inhibition by phenethylbiguanide of phosphoenolpyruvate synthesis in isolated guinea-pig liver mitochondria.
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The synthesis of glucose in mammalian liver involves a series of integrated reactions occurring in both the mitochondria and the cytosol. Gluconeogenesis requires the generation of NADH for a specific reduction step at the triose level of glycolysis as well as the synthesis of ATP within the mitochondria. Of particular importance in gluconeogenesis has been the use of inhibitors that specifically alter key reactions in the process. Biebuyck et al. (1972) have reported that halothane, a general anaesthetic, inhibits gluconeogenesis in rat liver, presumably by a direct action on the mitochondrial NADH dehydrogenase, as suggested by Cohen & Marshall (1968) . Studies in our laboratory using both the perfused rat and guinea-pig liver indicated that cycloheximide blocks gluconeogenesis from lactate, pyruvate and glycerol, when infused at concentrations (about 5mM) several orders of magnitude higher than that required to inhibit protein synthesis. This compound was also shown to block energy Vol. 144 transfer at NADH dehydrogenase (Site 1) of the electron-transport chain . Further, its action was rapid (2-4min for 60% inhibition) and completely reversible. Another compound which inhibits hepatic glucose synthesis and is also hypoglycaemic is diphenyleneiodonium (Holland et al., 1973) . It was shown to block the oxidation of NAD+-linked substrates at Site I of the respiratory chain in a manner similar to rotenone.
This relationship between inhibitors of energy transfer and hepatic glucose synthesis is perhaps best exemplified by the widely used hypoglycaemic agent phenethylbiguanide. This compound acts most specifically in guinea-pig liver [see Cook et al. (1973a) for a discussion of species differences in response to phenethylbiguanide]. The mechanism by which this compound acts has been investigated and its hypoglycaemic effect may be related to its role as an inhibitor of energy transfer (Haeckel & Haeckel, 1972; Jangaard et al., 1967; Davidoff, 1968a,b) . In the present paper we have further investigated the mechanism of phenethylbiguanide action on isolated guinea-pig liver mitochondria and have related our findings to the regulation of gluconeogenesis in the isolated perfused guinea-pig liver. 
Experimental

Isolation and incubation ofmitochondria
Liver mitochondria from rats and guinea pigs were isolated by differential centrifugation in 0.32M-sucrose and 4mM-Hepes [2-(N-2-hydroxyethylpiperazin-N'-yl)ethanesulphonic acid] buffer, pH7.35. After sedimentation of the nuclei (700g for 10min) the mitochondria were separated by centrifugation at 12 000g for 20min, then washed twice with 12vol. of the same buffer/g of liver used. Mitochondria (approx. 12mg of protein) were added to an incubation medium which contained, in a final volume of 3ml, 160mM-sucrose, 6.6mM-MgCl2, 20mM-potassium phosphate, 2mM-Hepes (pH7.5), 3mM-ADP and the appropriate substrates at the concentrations indicated in the Figures. The incubation was stopped with HC104 (final concn. 6%, w/v), the tubes were chilled in ice and the extracts neutralized with KHCO3. The resultant precipitate was removed by centrifugation and the concentrations of the various metabolites were measured enzymically. Mitochondrial protein was determined by its u.v. absorption, with bovine serum albumin as a standard, by the method of Layne (1957) .
For simultaneous studies of 02 consumption and ADP phosphorylation, a cuvette based on a model described by Pressman (1967) and Chance & Hagihara (1963) was adapted for use in a dualwavelength spectrophotometer. 02 consumption was measured with a Clark-type oxygen electrode, and changes in pH were monitored with a Radiometer combination glass electrode with amplification of the resulting signal. These determinations were performed simultaneously in a thermostatically controlled cuvette equipped with a stirring motor in which mitochondria were incubated at 25°C in 4.8ml of 0.25mM-sucrose buffer containing 5mM-potassium phosphate, 5mM-MgCI2 and 3.2mM-Hepes, pH7.5.
Determination of metabolites
The analysis of ATP, ADP, AMP, phosphoenolpyruvate, f-hydroxybutyrate, acetoacetate, lactate and pyruvate was performed by standard enzymic methods (Bergmeyer, 1965) . Glucose was measured by using a Technicon Autoanalyzer with the glucose oxidase-peroxidase system (Hill & Kessler, 1961) .
Liver perfusion
The animals used in this study were male SpragueDawley rats maintained on Wayne Lab Chow or guinea pigs of the Hartley strain fed on Wayne Guinea-Pig Chow. They were normally starved for 24 or 48h as indicated in the appropriate Figure  legends . The liver-perfusion technique has been described in detail by Jomain-Baum et al. (1973) . We used the liver-perfusion apparatus designed by Scholz (Scholz et al., 1966 ) with a non-recycling perfusion system. During the perfusion we continually For the measurement of adenine nucleotides the livers were freeze-clamped by using tongs precooled in liquid N2. The tissue was powdered in liquid N2, then homogenized in 6% (v/v) HCl04 and neutralized with KHCO3 for the measurement ofATP, ADPand AMP by standard enzymic methods (Bergmeyer, 1965) .
Results
The synthesis of phosphoenolpyruvate and ATP by isolated guinea-pig liver mitochondria metabolizing malate or 2-oxoglutarate was progressively inhibited by increasing concentrations of phenethylbiguanide over a range of 0.01-lmm ( Phenethylbiguanide was used at different concentrations from 0 to 1mM. The mitochondria were maintained for 20min in State 4 (Chance & Williams, 1956) , then placed in State 3 for 10min by the addition of 3mM-ADP.
The incubations were stopped by addition of ice-cold HClO4 and the chilled extracts were centrifuged and then neutralized before the enzymic determinations of metabolites. Bars denote ±S.E.M. for five determinations.
both guinea-pig and rat liver mitochondria were sensitive to phenethylbiguanide. At lower inhibitor concentrations (0.05mM) guinea-pig liver mitochondria were more sensitive (23 versus 8 % inhibition), whereas at higher concentrations mitochondria from both species appeared to be equally affected (60% inhibition). This point was noteworthy in view of the report by Cook et al. (1973b) Gluconeogenesis from lactate by guinea-pig liver was very sensitive to phenylbiguanide at low concentrations. Fig. 4 shows the result of a typical non-recycling perfusion in wbich phenethylbiguanide was introduced into the liver with a constant-infusion pump to give a final concentration of mm. The phenethylbiguanide was infused for 10min and it took an additional 10min before the inhibition of gluconeogenesis became evident. The depressive effect of phenethylbiguanide on glucose synthesis from lactate was irreversible, with the rate of gluconeogenesis not returning to normal values. 02 consumption was also decreased by phenethylbiguanide. As noted by Haeckel & Haeckel (1972) , phenethylbiguanide increased in the ,B-hydroxybutyrate/acetoacetate ratio as measured by the concentration of these ketone bodies in the perfusate coming from the liver, but this effect was noted immediately after the termination of phenethylbiguanide infusion. The inhibitory effect of phenethylbiguanide on hepatic gluconeogenesis by the guinea pig varied with the substrate infused. As shown in Fig. 5, a 10min infusion of phenethylbiguanide at the concentrations indicated had various effects on gluconeogenesis from the major gluconeogenic substrates. Gluconeogenesis from alanine was the most sensitive and that from glycerol the least. The reason for the extreme sensitivity of gluconeogenesis from alanine by isolated guinea-pig liver was not clear, but at 1 mM-phenethylbiguanide, a concentration that caused a 40% inhibition of glucose synthesis from lactate, there was a virtual cessation of synthesis from alanine within 20min after the termination of infusion of the inhibitor. In general, both the extent and time-course of inhibition of gluconeogenesis by phenethylbiguanide depended on the concentration ofinhibitor used. This is shown in Fig. 6 , whereglucose synthesis from both lactate and alanine was measured 30min after the start of the infusion of 1 mM-phenethylbiguanide for durations of infusion indicated in the Figure. The decline in hepatic gluconeogenesis from alaninewas negligible after 1 min ofphenethylbiguanide infusion but inhibition was almost total by 10min. Gluconeogenesis from lactate is less sensitive to phenethylbiguanide, but the inhibition of glucose synthesis showed the same time-dependence. In experiments not presented in this paper, we noted that the continued infusion of 0.1 mM-phenethylbiguanide guinea-pig liver mitochondria Mitochondria isolated from guinea-pig liver were incubated in the medium described in Fig. 1 in guinea-pig liver Livers from 48h-starved guinea pigs were perfused with Krebs-Ringer bicarbonate buffer, pH7.4, and at 30min either 2mM-lactate or -glycerol was infused. At 60min phenethylbiguanide was introduced with a constant-infusion pump to give a final concentration of 1 mm. The infusion of phenethylbiguanide was terminated after 10min (represented by vertical black blocks); lactate (a, c, e) or glycerol (b, d,f) was present for the entire 50min of perfusion. Glucose and ketone bodies were determined on samples of the perfusate as outlined in the Experimental section. The values for O°consumption and glucose synthesis were expressed as ,umol/min per g of liver. Bars denote the S.E.M. for five animals.
will cause an almost total inhibition ofgluconeogenesis from lactate within 40min. Thus both the time of exposure of the guinea-pig liver to phenethylbiguanide, as well as the concentration of the inhibitor Vol. 144 used, are important factors in determining the extent of the decrease in gluconeogenesis from the four substrates tested.
Rat liver is also sensitive to phenethylbiguanide. alanine.
Gluconeogenesis from pyruvate and lactate was inhibited, but only at relatively higher phenethylbiguanide concentrations (8mM), and as shown in Fig. 7 , the effect was at least partly reversible after the infusion ofthe inhibitor was terminated. We noted that the constant infusion of high concentrations of this compound would maintain the lower rate of glucose synthesis from both substrates in perfused rat liver (results not shown).
Discussion
Phenethylbiguanide is a widely used hypoglycaemic agent and its mechanism ofaction at the cellular level has been intensively studied since Ungar et al. (1957) first reported its effectiveness in diabetes. There is general agreement that phenethylbiguanide shares with the guanidines the ability to interfere with oxidative metabolism. Early work by Wick et al. (1958) indicated an inhibition of glucose and acetate oxidation by adipose tissue, and this effect was attributed to a block in the electron-transport chain between succinate dehydrogenase and a reduced cytochrome c. Since then a number of other demonstrations of phenethylbiguanide inhibition of respiration have been published [see Harsant (1969) Vol. 144 Time (min) Fig. 7 . Effect of phenethylbiguanide on gluconeogenesis from lactate or pyruvate by perfused rat liver Animals were starved for 24h and the livers isolated and perfused with 2mM-lactate (a) or -pyruvate (b) as outlined in Fig. 4 Davidoff (1968a Davidoff ( ,b, 1971 Davidoff ( , 1972 has extensively studied the mechanism of phenethylbiguanide accumulation and its relationship to respiratory inhibition in vitro. He demonstrated that phenethylbiguanide accumulates in guinea-pig heart mitochondria at a slow rate in part dependent on the affinity of the inhibitor for anionic binding sites (Davidoff, 1971) . The uptake of 3H-labelled phenethylbiguanide was also shown to be sensitive to pH changes in the mitochondrial incubation medium and to correlate well with the extent of respiratory inhibition. Also small amounts of long-chain fatty acids caused the transport of phenethylbiguanide in the absence of any effect on energy coupling or intramitochondrial pH. Schafer & Bojanowski (1972) reported that biguanides bind to the mitochondrial membrane in a rapid reaction, which was ten times faster than the observed inhibition of oxidative phosphorylation. During this initial binding phase, protons were released from the mitochondrial membrane. The affinity for binding was determined by the degree of hydrophobic interaction of the biguanides and the mitochondrial membrane, presumably with membrane phospholipids. These observations demonstrate the complex regulatory factors that control the rate of phenethylbiguanide uptake by mitochondria in vitro.
The association between the direct effect of phenethylbiguanide on isolated mitochondria and the inhibitory effect ofthis compound on gluconeogenesis in the intact liver is suggested by the almost identical time-course of inhibition noted in the two systems. There is also a concentration-dependent lag in the effective inhibition of phosphoenolpyruvate formation by guinea-pig liver mitochondria which corresponds to a lag in phenethylbiguanide inhibition of gluconeogenesis by the perfused liver. A similar delayed inhibition of glucose synthesis by rat liver perfused with 0.5mM-phenethylbiguanide was reported by Toews et al. (1970) , who noted a 15-20min lag period with lactate, pyruvate or alanine as substrates. We also found a difference in the degree of sensitivity of these substrates to phenethylbiguanide (see Figs. 5 and 7) and the lag time in the inhibition of gluconeogenesis is also different. This is clearly demonstrated in Fig. 6 , where the infusion of 1 mmphenethylbiguanide for 5min is twice as effective in inhibiting glucose synthesis from alanine as compared with lactate.
To simplify our considerations of the hypoglycaemic effect of phenethylbiguanide we have assumed that its action is caused by a single primary effect on the liver. This does not rule out other possible effects of phenethylbiguanide on other tissues such as intestinal mucosa (Kruger et al., 1970; Agid & Marquie, 1972; Wingate & Hadley, 1973) or muscle (Butterfield, 1968 (Garber & Hanson, 1971) and to be associated with a decreased rate of gluconeogenesis in perfused guinea-pig liver (Arinze et al., 1973) . Haeckel & Haeckel (1972) were the first to demonstrate that phenethylbiguanide can markedly shift the mitochondrial oxidationreduction state of guinea-pig liver toward reduction. Glucose formation from alanine would be especially sensitive to alterations in the mitochondrial NAD+/ NADH ratio, since the formation of 2-oxoglutarate from glutamate by glutamate dehydrogenase would be unfavourable for net 2-oxoglutarate synthesis. This may explain the greater sensitivity of alanine to the action of low concentrations of phenethylbiguanide, and its effect on conversion ofpyruvate into glucose further supports this point. However, concentrations (0.1 mM) of phenethylbiguanide that cause a 60% inhibition of gluconeogenesis from alanine by 30min of infusion also cause a small but significant stimulation of gluconeogenesis from pyruvate (see Fig. 5 ). Other compounds such as glycerol, which are less clearly influenced by changes in the mitochondrial oxidation-reduction state, are also less sensitive to the infusion of phenethylbiguanide.
It has been known for some time that phenethylbiguanide is relatively ineffective as a hypoglycaemic agent in the rat (Altschuld & Kruger, 1968) . This contrasts with the situation in the human (Pomeranye et al., 1957) and in the guinea pig. Cook et al. (1973a) have reported that phenethylbiguanide is metabolized by rat liver microsomal preparations to p-hydroxyphenethylbiguanide, a metabolically inactive compound, to a greater extent than was observed with guinea-pig liver. If microsomal hydroxylation was inhibited by the infusion of 2,4-dichloro-6-phenylphenoxyethyldiethylamine hydrobromide (Lilly 18947), gluconeogenesis by rat liver was inhibited by phenethylbiguanide. Although this finding undoubtedly accounts for the major differences in species reactivity to phenethylbiguanide, it is also evident that mitochondria isolated from 1974 guinea-pig liver are more sensitive to the inhibitor than are rat liver mitochondria. The rate of ATP formation by guinea-pig liver mitochondria is inhibited at a lower concentration of phenethylbiguanide than was found for rat liver mitochondria respiring with malate plus glutamate. We have demonstrated (Fig. 7) that gluconeogenesis in rat liver perfused with lactate or pyruvate can be inhibited by phenethylbiguanide, if the concentration of the inhibitor is raised to a high value (8mM). In these studies a single 10min infusion of phenethylbiguanide was used and the effects on conversion of both pyruvate and lactate into glucose was reversible. It then seems likely that phenethylbiguanide will effectively inhibit gluconeogenesis from most substrates in both rat and guinea-pig liver, if the concentration of the inhibitor is raised to values that effectively overcome the mechanisms that remove it, presumably its hydroxylation by the hepatic microsomal preparations. It is also clear that Site 1 inhibitors such as phenethylbiguanide, cycloheximide and diphenyleneiodonium are effective gluconeogenic inhibitors in both rat and guinea-pig liver. The shift in oxidation-reduction state of the mitochondria toward reduction noted in both species is probably not responsible for the dramatic fall in glucose synthesis noted in guinea-pig liver, but rather some, as yet not clearly understood, relationship between ATP formation at Site 1 and hepatic gluconeogenesis.
